Head of the Lung and Resuscitation Group, Calum Roberts is a Senior Research Fellow in the Department of Paediatrics, Monash University, and is a Consultant Neonatologist at Monash Children’s Hospital. He is the current recipient of an NHMRC Early Leadership Grant.

Calum completed his MBChB at the University of Edinburgh, and did his clinical neonatal training in Scotland, the north of England, and Melbourne. He was awarded his PhD by the University of Melbourne for research into the use of nasal High Flow treatment in preterm infants, with Prof. Peter Davis’s team at the Royal Women’s Hospital. Calum joined Monash University in 2017.

Calum’s work has substantially influenced international clinical guidelines in neonatal respiratory support, including the HIPSTER, HUNTER, and SHINE trials of nasal High Flow treatment, all published in the New England Journal of Medicine. His research has also appeared in leading paediatric journals such as JAMA Pediatrics, Pediatrics, and Archives of Disease in Childhood Fetal and Neonatal Edition. He has been the recipient of a Society for Pediatric Research (USA) PhD student research award, and a commendation at the 2017 Victorian Premier’s Award for Health and Medical Research. He has previously chaired the Perinatal Society of Australia and New Zealand’s Early Career Research Executive Committee, and served as a committee member for state-wide guidance developed by SaferCare Victoria. He is an organising committee member for the Neonatal Resuscitation Research Workshop, a biennial meeting of the world’s leading researchers in newborn resuscitation.

Calum's research focus is improving outcomes for preterm and sick newborn infants, and their families. He has a particular interest in neonatal resuscitation and respiratory management. 

Calum and his team currently lead two major NHMRC-funded clinical trials. The SURFSUP Trial (ACTRN12620001184965) and the neoGASTRIC Trial (ISRCTN16710849). Calum collaborates on a number of other multi-centre trials with colleagues from Australia, New Zealand, the UK, Canada, the Netherlands, and Norway. These include the AIROPLANE, Circa Diem, and PinC trials.

In collaboration with Prof Stuart Hooper and Prof Graeme Polglase of The Ritchie Centre, Calum conducts a program of preclinical work focused on understanding the response to resuscitation, and identifying new treatment strategies, in the setting of severe birth asphyxia.

Calum has successfully secured more than $7 million in research funding in support of this program, from the NHMRC, NIHR, Heart Foundation, and Cerebral Palsy Alliance.